COLON CANCER TUMOR SUPPRESSOR GENE, B-DEFENSIN 1, PREDICTS RECURRENCE IN PATIENTS WITH STAGE II AND III COLON CANCER

摘要

The disclosure provides compositions and methods for determining the likely tumor recurrence in cancer patients by screening one or more of DEFB1 rs1800972 C/G or rs1799946 A/G polymorphism in samples isolated from the patient.